Εμφάνιση απλής εγγραφής

dc.creatorPapatsiros V., Tzika E., Athanasiou L., Tassis P., Chaintoutis S., Christodoulopoulos G.en
dc.date.accessioned2023-01-31T09:45:00Z
dc.date.available2023-01-31T09:45:00Z
dc.date.issued2019
dc.identifier10.1089/mdr.2018.0277
dc.identifier.issn10766294
dc.identifier.urihttp://hdl.handle.net/11615/77871
dc.description.abstractThe aim of this trial was to evaluate the in vivo effectiveness of injectable antibiotics of one-or two-dose administration on recovery of acute App (Actinobacillus pleuropneumoniae)-infected pigs. Ninety pigs with moderate general clinical score (GCS) of a commercial farm, suffering from acute App infection, were divided in two groups: (a) T1: one administration of gamithromycin injectable solution and (b) T2: Two administrations of florfenicol injectable solution. Morbidity/mortality, clinical scores (clinical appearance score index-CAS, clinical respiratory score-CRS, clinical cough score index [CCS], general respiratory clinical score-GCRS, and general clinical score-GCS), body temperature score (BTS), and posttreatment interval were recorded. The carcass weight and lung scoring were estimated, based on slaughterhouse pleurisy evaluation system score, lung lobes score, and pneumonia area. The results of this study indicated that the tested antibiotics are efficacious for the recovery of acute App-Affected pigs. Quicker improvement of BTS in sick pigs (at day 1 and 2) and quicker recovery of clinical signs, based on the improvement of clinical parameters (CAS, CCS, GCRS, GCS on day 2 and 3, and CRS on day 2), were noticed in T1 group. In conclusion, the use of tested antibiotics in acute App-Affected pigs is an effective strategy for the control of an acute outbreak. © Copyright 2019, Mary Ann Liebert, Inc., publishers 2019.en
dc.language.isoenen
dc.sourceMicrobial Drug Resistanceen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85065817047&doi=10.1089%2fmdr.2018.0277&partnerID=40&md5=cf6d6038bf587515e5512fdb2928a696
dc.subjectflorfenicolen
dc.subjectgamithromycinen
dc.subjectivermectinen
dc.subjectantiinfective agenten
dc.subjectflorfenicolen
dc.subjectthiamphenicolen
dc.subjectActinobacillus pleuropneumoniaeen
dc.subjectanimal experimenten
dc.subjectantibiotic therapyen
dc.subjectArticleen
dc.subjectbody temperatureen
dc.subjectcohort analysisen
dc.subjectcoughingen
dc.subjectdrug efficacyen
dc.subjectin vivo studyen
dc.subjectlung lobeen
dc.subjectmorbidityen
dc.subjectmortalityen
dc.subjectnonhumanen
dc.subjectpigen
dc.subjectpleurisyen
dc.subjectporcine pleuropneumoniaen
dc.subjectpriority journalen
dc.subjectslaughterhouseen
dc.subjectActinobacillus infectionen
dc.subjectActinobacillus pleuropneumoniaeen
dc.subjectanimalen
dc.subjectdrug effecten
dc.subjectlungen
dc.subjectmicrobiologyen
dc.subjectswine diseaseen
dc.subjectveterinary medicineen
dc.subjectAbattoirsen
dc.subjectActinobacillus Infectionsen
dc.subjectActinobacillus pleuropneumoniaeen
dc.subjectAnimalsen
dc.subjectAnti-Bacterial Agentsen
dc.subjectLungen
dc.subjectSwineen
dc.subjectSwine Diseasesen
dc.subjectThiamphenicolen
dc.subjectMary Ann Liebert Inc.en
dc.titleIn vivo effectiveness of injectable antibiotics on the recovery of acute actinobacillus pleuropneumoniae-infected pigsen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής